Vectra Felis

RSS

pyriproxyfen / dinotefuran

Authorised
This medicine is authorised for use in the European Union.

Overview

Vectra Felis is a veterinary medicine used to treat and prevent flea infestations in cats. It also prevents fleas from hatching and developing in the cat’s environment.

This EPAR was last updated on 19/11/2019

Authorisation details

Product details
Name
Vectra Felis
Agency product number
EMEA/V/C/002746
Active substance
  • pyriproxyfen
  • dinotefuran
International non-proprietary name (INN) or common name
pyriproxyfen / dinotefuran
Species
Cats
Anatomical therapeutic chemical veterinary (ATCvet) codes
QP53AX73
Publication details
Marketing-authorisation holder
CEVA Santé Animale
Revision
3
Date of issue of marketing authorisation valid throughout the European Union
06/06/2014
Contact address

Ceva Santé Animale
10, av. de La Ballastière
33500 Libourne
France

Product information

12/09/2019 Vectra Felis - EMEA/V/C/002746 - II/0009

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
  • Other ectoparasiticides for topical use
  • pyriproxyfen, combinations

Therapeutic indication

Treatment and prevention of flea infestations (Ctenocephalides felis) on cats.

One application prevents flea infestation for one month. It also prevents the multiplication of fleas by inhibiting flea emergence in the environment of the cat for 3 months.

Assessment history

How useful was this page?

Add your rating